FDA Approves Simplified Prefilled Syringe Option for GSK’s Shingrix

FDA approves simplified prefilled syringe option for GSK’s Shingrix

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster vaccine for adult patients.

A broken system fails patients

A recent study has concluded, the recombinant shingles vaccine is associated with a lower risk of dementia. There is a history of dementia in the male side of my family, and since I also am unlucky enough to suffer from…

FDA Approves GSK’s Shingles Vaccine in Prefilled Syringe

The new presentation of Shingrix will allow for easier administration.

GSK receives US FDA approval for Shingrix

The FDA has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a prefilled syringe presentation to prevent shingles.

FDA Approves Prefilled Vaccine Presentation for Shingrix

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for healthcare professionals.

FDA Approves Zoster Vaccine Recombinant Prefilled Syringe Presentation for Shingles Prevention

The FDA approves a prefilled syringe for the zoster vaccine recombinant, enhancing shingles vaccination convenience and effectiveness for adults 50 and older.